Join PharmScript, LLC. on Thursday, April 11th, from 2:00 to 3:00 p.m. EDT. Matthew Jaco, Medical Science Liaison with Acadia Pharmaceuticals, will present the webinar.

Matthew will share the following learning objectives:

Learning Objectives

1. Understand Parkinson’s Disease and Parkinson’s Disease Psychosis, a non-motor aspect of Parkinson’s.

2. Review appropriate management of hallucinations and delusions associated with Parkinson’s Disease Psychosis.

3. Review clinical efficiency and safety data of Nuplazid to treat Parkinson’s Disease Psychosis.

The webinar is for informational purposes only. No CEUs will be provided

Register today: click here